New PET tracer improves tumor detection of medullary thyroid cancer tumors and demonstrates potential for targeted therapy.
A newly developed PET imaging agent has been shown to be effective in detecting medullary thyroid cancer (MTC) in preclinical and clinical trials. The results of the study indicate that this PET imaging agent may be a promising therapeutic candidate for clinical use.
The results of the study were published in the Journal of Nuclear Medicine.
CRC is one of the rarest forms of thyroid cancer, accounting for about 3% of all cases. Because CRC arises from different cells than most thyroid cancers, these patients require different imaging and therapeutic targets.
The cholecystokinin-2 receptor (CCK-2R) is overexpressed in most thyroid cancer cells, and various compounds targeting CCK-2R have been developed over the past few years. However, most of these compounds have low metabolic stability, making them less ideal for radioligand therapy. Our team attempted to design several theranostic agents and evaluate their efficacy using simplified design modifications to address the instability issue.”
In the study, three compounds (DOTA-CCK-66, DOTA-CCK 66.2 and external reference DOTA-MGS5) were separately labeled with 64Cu, 67Ga and 177Lu, respectively. The affinity for CCK-2R of each radiolabeled compound was investigated in MTC cells; all three compounds showed high affinity, but DOTA-CCK-66.2 was excluded from further studies due to the better in vitro properties of DOTA-CCK-66.
Stability, biodistribution, imaging and in vivo competition studies were then performed on mice with tumors expressing CCK-2R.68Ga-DOTA-DOTA-CCK-66 was selected for a PET/CT trial based on its overall in vitro and in vivo properties.
Two patients with RRM subsequently underwent PET/CT with 68Ga-DOTA-CCK-66. The compound was well tolerated, showed good biodistribution and high tumor-accumulating activity.
Due to its improved in vivo stability, our compound is well absorbed by tumor and better eliminated from target tissues. This allows for improved lesion detection on PET imaging and further targeted radioligand therapy for MTC,” said Konstantin Lapa, MD, Head of the Department of Nuclear Medicine, University Hospital Augsburg, Augsburg, Germany.
Gunther and Lapa added, “An important result of our study is the idea that pharmacokinetics can be optimized by chemical design. Analyzing the weaknesses of existing compounds and systematically addressing them to improve imaging and therapy is crucial for future clinical applications.”
The study was published online in November 2023.
The authors of the paper are Thomas Günther, Nadine Holzleitner, Roswitha Beck, Hans-Jürgen Wester (Department of Chemistry, Department of Pharmaceutical Radiochemistry, Faculty of Natural Sciences, TUM, Munich University of Technology, Garching, Germany), Oliver Wiering, Georgine Wynand, Alexander Dirks, Christian H. Pfob, Ralf A. Bundschuh, Malte Kircher and Konstantin Lapa (Department of Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany).
Combined thyroid hormone therapy treats hypothyroidism in the same way as levothyroxine.
Treatment of hypothyroidism caused by underactive thyroid should be individualized, and alternatives to first-line therapy, such as dry thyroid extract or combination therapy to replace the two major thyroid hormones, thyroxine (T4) and triiodothyronine (T3), should be considered. Results of the new randomized clinical trial will be presented at ENDO 2021, the annual meeting of […]
COVID-19 Vaccination Appears Safe for Patients Treated for Hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients being treated for hypothyroidism, according to a new study presented at the Endocrine Society Annual Meeting ENDO2022 in Atlanta, Georgia. The study found that these vaccines do not cause significant changes in thyroid function and are not associated with an increased risk of emergency […]
What happens when the thyroid gland is working too hard or not hard enough?
January is Thyroid Awareness Month and a good time to learn how important it is for the thyroid gland to function properly. The thyroid gland is a butterfly-shaped gland located at the base of the neck. It produces hormones that regulate heart rate, blood pressure, body temperature, and weight. If the thyroid gland is not […]
The Efficacy and Side Effects of Antidepressants in the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis.
Antidepressants in the Treatment of Major Depressive Disorder What is the efficacy of antidepressants in treating major depressive disorder? Antidepressants are common prescription medications used to treat major depressive disorder and other conditions. Antidepressants have been shown to be effective in treating depressive symptoms and may be more effective than other medications in some individuals. […]
A million Americans may take drugs with hypothyroidism that they don’t need.
As many as 90% of people taking Levothyroxine [synthroid] may have been unnecessarily prescribed medications for hypothyroidism. About 23 million Americans take levothyroxine, making it one of the most prescribed drugs in the country 1. To test for hypothyroidism (hypothyroidism), clinicians measure levels of thyroid-stimulating hormone (TSH) and free thyroxine (free T4). However, the new […]
Many patients with autoimmune diseases face problems of diagnosis, cost, and inattentive care
After years of suffering from bouts of debilitating fatigue, Beth Van Orden thought she had finally found the answer to her problem when she was diagnosed with Hashimoto’s autoimmune disease in 2016. Hypothyroidism is a condition in which the butterfly-shaped thyroid gland located in the neck stops producing enough hormones needed to regulate the body’s […]